These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 26895833)
1. MLN4924, a First-in-Class NEDD8-Activating Enzyme Inhibitor, Attenuates IFN-β Production. Song H; Huai W; Yu Z; Wang W; Zhao J; Zhang L; Zhao W J Immunol; 2016 Apr; 196(7):3117-23. PubMed ID: 26895833 [TBL] [Abstract][Full Text] [Related]
2. Neddylation-Independent Activities of MLN4924. Mao H; Sun Y Adv Exp Med Biol; 2020; 1217():363-372. PubMed ID: 31898238 [TBL] [Abstract][Full Text] [Related]
3. Neddylation is required for herpes simplex virus type I (HSV-1)-induced early phase interferon-beta production. Zhang X; Ye Z; Pei Y; Qiu G; Wang Q; Xu Y; Shen B; Zhang J Cell Mol Immunol; 2016 Sep; 13(5):578-83. PubMed ID: 27593482 [TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptor gamma negatively regulates IFN-beta production in Toll-like receptor (TLR) 3- and TLR4-stimulated macrophages by preventing interferon regulatory factor 3 binding to the IFN-beta promoter. Zhao W; Wang L; Zhang M; Wang P; Zhang L; Yuan C; Qi J; Qiao Y; Kuo PC; Gao C J Biol Chem; 2011 Feb; 286(7):5519-28. PubMed ID: 21148557 [TBL] [Abstract][Full Text] [Related]
5. The Nedd8-activating enzyme inhibitor MLN4924 induces autophagy and apoptosis to suppress liver cancer cell growth. Luo Z; Yu G; Lee HW; Li L; Wang L; Yang D; Pan Y; Ding C; Qian J; Wu L; Chu Y; Yi J; Wang X; Sun Y; Jeong LS; Liu J; Jia L Cancer Res; 2012 Jul; 72(13):3360-71. PubMed ID: 22562464 [TBL] [Abstract][Full Text] [Related]
6. MLN4924: a novel first-in-class inhibitor of NEDD8-activating enzyme for cancer therapy. Nawrocki ST; Griffin P; Kelly KR; Carew JS Expert Opin Investig Drugs; 2012 Oct; 21(10):1563-73. PubMed ID: 22799561 [TBL] [Abstract][Full Text] [Related]
7. Targeting protein neddylation with an NEDD8-activating enzyme inhibitor MLN4924 induced apoptosis or senescence in human lymphoma cells. Wang Y; Luo Z; Pan Y; Wang W; Zhou X; Jeong LS; Chu Y; Liu J; Jia L Cancer Biol Ther; 2015; 16(3):420-9. PubMed ID: 25782162 [TBL] [Abstract][Full Text] [Related]
8. Suppression of glioblastoma by targeting the overactivated protein neddylation pathway. Hua W; Li C; Yang Z; Li L; Jiang Y; Yu G; Zhu W; Liu Z; Duan S; Chu Y; Yang M; Zhang Y; Mao Y; Jia L Neuro Oncol; 2015 Oct; 17(10):1333-43. PubMed ID: 25904638 [TBL] [Abstract][Full Text] [Related]
9. MLN4924 (Pevonedistat), a protein neddylation inhibitor, suppresses proliferation and migration of human clear cell renal cell carcinoma. Tong S; Si Y; Yu H; Zhang L; Xie P; Jiang W Sci Rep; 2017 Jul; 7(1):5599. PubMed ID: 28717191 [TBL] [Abstract][Full Text] [Related]
10. Overactivated neddylation pathway as a therapeutic target in lung cancer. Li L; Wang M; Yu G; Chen P; Li H; Wei D; Zhu J; Xie L; Jia H; Shi J; Li C; Yao W; Wang Y; Gao Q; Jeong LS; Lee HW; Yu J; Hu F; Mei J; Wang P; Chu Y; Qi H; Yang M; Dong Z; Sun Y; Hoffman RM; Jia L J Natl Cancer Inst; 2014 Jun; 106(6):dju083. PubMed ID: 24853380 [TBL] [Abstract][Full Text] [Related]
11. MLN4924 is an efficient inhibitor of NEDD8 conjugation in plants. Hakenjos JP; Richter R; Dohmann EM; Katsiarimpa A; Isono E; Schwechheimer C Plant Physiol; 2011 Jun; 156(2):527-36. PubMed ID: 21527421 [TBL] [Abstract][Full Text] [Related]
12. LY294002 inhibits TLR3/4-mediated IFN-β production via inhibition of IRF3 activation with a PI3K-independent mechanism. Zhao W; Qi J; Wang L; Zhang M; Wang P; Gao C FEBS Lett; 2012 Mar; 586(6):705-10. PubMed ID: 22285490 [TBL] [Abstract][Full Text] [Related]
13. Neddylation inhibitor MLN4924 suppresses growth and migration of human gastric cancer cells. Lan H; Tang Z; Jin H; Sun Y Sci Rep; 2016 Apr; 6():24218. PubMed ID: 27063292 [TBL] [Abstract][Full Text] [Related]
14. Inhibiting Neddylation with MLN4924 Suppresses Growth and Delays Multicellular Development in Huber RJ; Kim WD; Mathavarajah S Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33807046 [TBL] [Abstract][Full Text] [Related]
15. Neddylation Pathway as a Novel Anti-cancer Target: Mechanistic Investigation and Therapeutic Implication. Jiang Y; Jia L Anticancer Agents Med Chem; 2015; 15(9):1127-33. PubMed ID: 25742093 [TBL] [Abstract][Full Text] [Related]
16. Substrate-assisted inhibition of ubiquitin-like protein-activating enzymes: the NEDD8 E1 inhibitor MLN4924 forms a NEDD8-AMP mimetic in situ. Brownell JE; Sintchak MD; Gavin JM; Liao H; Bruzzese FJ; Bump NJ; Soucy TA; Milhollen MA; Yang X; Burkhardt AL; Ma J; Loke HK; Lingaraj T; Wu D; Hamman KB; Spelman JJ; Cullis CA; Langston SP; Vyskocil S; Sells TB; Mallender WD; Visiers I; Li P; Claiborne CF; Rolfe M; Bolen JB; Dick LR Mol Cell; 2010 Jan; 37(1):102-11. PubMed ID: 20129059 [TBL] [Abstract][Full Text] [Related]
17. Validation of NEDD8-conjugating enzyme UBC12 as a new therapeutic target in lung cancer. Li L; Kang J; Zhang W; Cai L; Wang S; Liang Y; Jiang Y; Liu X; Zhang Y; Ruan H; Chen G; Wang M; Jia L EBioMedicine; 2019 Jul; 45():81-91. PubMed ID: 31208947 [TBL] [Abstract][Full Text] [Related]
18. NEDD8-mediated neddylation is required for human endometrial stromal proliferation and decidualization. Liao Y; Jiang Y; He H; Ni H; Tu Z; Zhang S; Wang B; Lou J; Quan S; Wang H Hum Reprod; 2015 Jul; 30(7):1665-76. PubMed ID: 26003431 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemia. Khalife J; Radomska HS; Santhanam R; Huang X; Neviani P; Saultz J; Wang H; Wu YZ; Alachkar H; Anghelina M; Dorrance A; Curfman J; Bloomfield CD; Medeiros BC; Perrotti D; Lee LJ; Lee RJ; Caligiuri MA; Pichiorri F; Croce CM; Garzon R; Guzman ML; Mendler JH; Marcucci G Leukemia; 2015 Oct; 29(10):1981-92. PubMed ID: 25971362 [TBL] [Abstract][Full Text] [Related]
20. Neddylation Inactivation Facilitates FOXO3a Nuclear Export to Suppress Estrogen Receptor Transcription and Improve Fulvestrant Sensitivity. Jia X; Li C; Li L; Liu X; Zhou L; Zhang W; Ni S; Lu Y; Chen L; Jeong LS; Yu J; Zhang Y; Zhang J; He S; Hu X; Sun H; Yu K; Liu G; Zhao H; Zhang Y; Jia L; Shao ZM Clin Cancer Res; 2019 Jun; 25(12):3658-3672. PubMed ID: 30833270 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]